[Antifungal agents for onychomycoses].

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Revista Iberoamericana de Micologia

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.riam.2010.01.007PMID 20346303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost Effectiveness of Continuous Terbinafine Compared with Intermittent Itraconazole in the Treatment of Dermatophyte Toenail Onychomycosis

  2012cited by this paper
• Cost of Treatment for Onychomycosis

  2012cited by this paper
• Cost of Treatment for Onychomycosis Data from a 9-Month Observational Study

  2012cited by this paper
• Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model

  2009cited by this paper
• Review of antifungal therapy and the severity index for assessing onychomycosis: Part I

  2008cited by this paper
• Onychomycosis--epidemiology, diagnosis and management.

  2008influential reference
• Update on Azole Antifungals

  2008cited by this paper
• Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.

  2008cited by this paper
• Antifungal agents – clinical pharmacokinetics and drug interactions

  2008cited by this paper
• Enhancing the nail permeability of topically applied drugs

  2008influential reference
• Update in Antifungal Therapy of Dermatophytosis

  2008influential reference
• Toenail onychomycosis: current and future treatment options

  2007cited by this paper
• Antifungal agents

  2007cited by this paper
• Clinical pharmacokinetics of systemically administered antimycotics.

  2007cited by this paper
• Frequent premature ventricular contractions induced by itraconazole.

  2007cited by this paper
• AN-2690, a novel antifungal for the topical treatment of onychomycosis.

  2007cited by this paper
• In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.

  2007cited by this paper
• Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial

  2007cited by this paper
• The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.

  2007cited by this paper
• Onychomycosis in the Elderly

  2007cited by this paper
• Delivery of Itraconazole from Extruded HPC Films

  2007cited by this paper
• A review of the new antifungals: posaconazole, micafungin, and anidulafungin.

  2007cited by this paper
• An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.

  2007cited by this paper
• Utilisation des antifongiques topiques

  2006cited by this paper
• In Vitro Activities of 10 Combinations of Antifungal Agents against the Multiresistant Pathogen Scopulariopsis brevicaulis

  2006cited by this paper
• Voriconazole Susceptibilities of Dermatophyte Isolates Obtained from a Worldwide Tinea Capitis Clinical Trial

  2006cited by this paper
• Antifúngicos: mecanismo de acción en células de levaduras

  2006cited by this paper
• [Use of topical antifungal agents].

  2006cited by this paper
• Pharmacoeconomic Assessment of Ciclopirox Topical Solution, 8%, Oral Terbinafine, and Oral Itraconazole for Onychomycosis

  2006cited by this paper
• Nail Penetration of Sertaconazole with a Sertaconazole-Containing Nail Patch Formulation

  2006cited by this paper
• Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy

  2005cited by this paper
• Estudio de satisfacción con el tratamiento de las micosis en extremidades con terbinafina (SETTA)

  2005cited by this paper
• [Study on patient satisfaction with the treatment of mycosis on the extremities with terbinafine (SETTA)].

  2005cited by this paper
• Sertaconazole: updated review of a topical antifungal agent

  2005cited by this paper
• An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis.

  2005cited by this paper
• Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%.

  2005cited by this paper
• Treatment options – development of consensus guidelines

  2005cited by this paper
• Actividad antifúngica in vitro de voriconazol contra dermatofitos y aislamientos superficiales de Scopulariopsis brevicaulis

  2005cited by this paper
• The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence.

  2005cited by this paper
• Pharmacotherapy of onychomycosis

  2005influential reference
• New insights into the effect of amorolfine nail lacquer

  2005cited by this paper
• Evaluation of the Drug Treatment and Persistence of Onychomycosis

  2004cited by this paper
• Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study

  2004cited by this paper
• A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.

  2004cited by this paper
• Treatment of Onychomycosis: Pros and Cons of Antifungal Agents

  2004cited by this paper
• Current developments in anti-fungal agents

  2004cited by this paper
• Optimal Management of Fungal Infections of the Skin, Hair, and Nails

  2004cited by this paper
• Onychomycosis in Denmark: prevalence of fungal nail infection in general practice

  2004cited by this paper
• Onychomycosis: management and treatment. Proceedings of a clinical roundtable.

  2004cited by this paper
• Management of onychomycosis: examining the role of monotherapy and dual, triple, or quadruple therapies.

  2004influential reference
• Intracutaneous Distributions of Fluconazole, Itraconazole, and Griseofulvin in Guinea Pigs and Binding to Human Stratum Corneum

  2004cited by this paper
• Onychomycosis in clinical practice: factors contributing to recurrence.

  2003influential reference
• Combination therapy for onychomycosis.

  2003cited by this paper
• How to improve cure rates for the management of onychomycosis.

  2003influential reference
• The use of topical therapies to treat onychomycosis.

  2003cited by this paper
• Satisfaction with onychomycosis treatment. Pulse versus continuous dosing.

  2003cited by this paper
• Actividad in vitro de voriconazol y otros tres antifúngicos frente a dermatofitos

  2003cited by this paper
• [In vitro activity of voriconazole and three other antifungal agents against dermatophytes].

  2003cited by this paper
• Traitement des onychomycoses.

  2003cited by this paper
• Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis

  2003cited by this paper
• Pharmacoeconomic issues in onychomycosis.

  2003cited by this paper
• Drug synergies and the potential for combination therapy in onychomycosis.

  2003cited by this paper
• [The management of onychomycosis].

  2003cited by this paper
• Inappropriate use of oral terbinafine in family practice

  2003cited by this paper
• In vitro Activity of Sertaconazole against Dermatophyte Isolates with Reduced Fluconazole Susceptibility

  2003cited by this paper
• Therapeutic Efficacy of Topically Applied KP-103 against Experimental Tinea Unguium in Guinea Pigs in Comparison with Amorolfine and Terbinafine

  2002cited by this paper
• [Current treatment of dermatophytosis].

  2002cited by this paper
• Therapeutic Efficacy of Topically Applied KP-103 against Experimental Tinea Unguium in Guinea Pigs in Comparison with Amorolfine and Terbinafine

  2002cited by this paper
• Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.

  2002cited by this paper
• [Current treatment of onychomycosis].

  2002cited by this paper
• Tratamiento actual de las onicomicosis

  2002influential reference
• Ciclopirox nail lacquer: a brush with onychomycosis.

  2001cited by this paper
• Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost‐effective treatment for onychomycosis

  2001cited by this paper
• Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain

  2001cited by this paper
• Terbina®ne-induced hepatic dysfunction

  2001cited by this paper
• In Vitro Activities of 10 Antifungal Drugs against 508 Dermatophyte Strains

  2001cited by this paper
• ACE inhibition and renovascular disease.

  2001cited by this paper
• The future of onychomycosis therapy may involve a combination of approaches

  2001influential reference
• Terbinafine-induced hepatic dysfunction.

  2001cited by this paper
• Which antifungal agent for onychomycosis? A pharmacoeconomic analysis.

  2001influential reference
• Comparison of In Vitro Activities of Voriconazole and Five Established Antifungal Agents against Different Species of Dermatophytes Using a Broth Macrodilution Method

  2001cited by this paper
• Ciclopirox nail lacquer and podiatric practice.

  2000cited by this paper
• In vitro antifungal susceptibility methods and clinical implications of antifungal resistance.

  2000cited by this paper
• Onychomycosis. Treatment, quality of life, and economic issues.

  2000cited by this paper
• Onychomycosis in Children: Treatment with Bifonazole‐Urea

  2000cited by this paper
• [Onychomycoses caused by non-dermatophytic filamentous fungi in Cádiz].

  2000cited by this paper
• Ciclopirox nail lacquer solution 8% in the 21st century.

  2000cited by this paper
• Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis

  2000cited by this paper
• Ciclopirox nail lacquer topical solution 8%.

  2000cited by this paper
• Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.

  2000cited by this paper
• Comparative in vitro Antifungal Activity of Amphotericin B Lipid Complex, Amphotericin B and Fluconazole

  2000cited by this paper
• Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.

  2000cited by this paper
• Antifungal agents

  1999cited by this paper
• In Vitro Antifungal Susceptibilities ofScopulariopsis Isolates

  1999cited by this paper
• Activity of terbinafine against serious fungal pathogens

  1999cited by this paper
• [New antifungal drugs. Present and future].

  1999cited by this paper
• In Vitro Activity of Syn-2869, a Novel Triazole Agent, against Emerging and Less Common Mold Pathogens

  1999cited by this paper
• [Topical treatment of onychomycosis by occlusive dressing using bifonazole cream containing 40% urea].

  1998cited by this paper
• How Should Managed Care Treat Onychomycosis

  1998cited by this paper
• In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin

  1998cited by this paper

• A STUDY ON THE RETENTION BEHAVIOR OF SOME IMIDAZOLE ANTIMYCOTIC DRUGS IN ACETONITRILE-WATER BINARY MIXTURES

  2022cites this paper
• Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial

  2022cites this paper
• DETERMINATION OF CHROMATOGRAPHIC PROTONATION CONSTANTS OF SOME IMIDAZOLE ANTIMYCOTIC DRUGS IN ACETONITRILE-WATER BINARY MIXTURES

  2022cites this paper
• Onychomycosis of rare etiology.

  2022cites this paper
• Actividad combinada de itraconazol y terbinafina sobre aislamientos clínicos de Neoscytalidium dimidiatum

  2021cites this paper
• Onicomicosis de rara etiología

  2021cites this paper
• Onicomicosis por Trichophyton rubrum: presentación de un caso clínico

  2020influential citation
• Virulence Factors and Antifungal Susceptibility in Candida Species Isolated from Dermatomycosis Patients

  2020cites this paper
• Chitosan-hydroxypropyl methylcellulose tioconazole films: A promising alternative dosage form for the treatment of vaginal candidiasis.

  2019cites this paper
• Efecto antimicotico del jabon elaborado a base del extracto acuoso de los granos de Chenopodium quinoa “quinua” frente a Candida albicans

  2019cites this paper
• Leukonychia in HIV Patients

  2018cites this paper
• Development of a New Formulation for Onychomycosis Treatment Using Furvina® as an Active Pharmaceutical Ingredient

  2017cites this paper
• 13 Mycotic Leukonychia in HIV Patients

  2017cites this paper
• Spray-dried powders improve the controlled release of antifungal tioconazole-loaded polymeric nanocapsules compared to with lyophilized products.

  2016cites this paper
• [Evaluation of the in vitro susceptibility pattern of clinical isolates of Trichophyton mentagrophytes and Trichophyton rubrum in Santiago, Chile].

  2015cites this paper
• [Species distribution and antifungal susceptibility of Candida spp. causing superficial mycosis. Coro, Falcon state, Venezuela].

  2015cites this paper
• [In vitro antifungal susceptibility profile of Scopulariopsis brevicaulis isolated from onychomycosis].

  2015cites this paper
• Tratamiento con láser para la onicomicosis

  2015cites this paper
• Clinical, epidemiological, and therapeutic profile of dermatophytosis

  2014cites this paper
• Sensibilidad al fluconazol de aislamientos de Trichophyton rubrum

  2014cites this paper
• Aspergillus terreus complex: an emergent opportunistic agent of Onychomycosis

  2013cites this paper
• [Influence of the ecological group on the in vitro antifungal susceptibility of dermatophytic fungi].

  2013cites this paper
• Onicomicosis: epidemiología, agentes causales y evaluación de los métodos diagnósticos de laboratorio

  2012cites this paper
• Agentes etiológicos de onicomicosis diagnosticadas en el laboratorio de micología médica de la Universidad de Costa Rica.

  2012cites this paper
• Synergism between clotrimazole and cinnamon oil: An effective (weapon) drug in vitro and in vivo against some multi drug resistant dermatophytes

  2012cites this paper
• Etiological agents of onychomycosis diagnosed in the medical mycology laboratory of the University of Costa Rica.

  2012cites this paper
• [Onychomycosis: multicentre epidemiological, clinical and mycological study].

  2012cites this paper
• Update on the Treatment of Superficial Mycoses

  2012cites this paper
• Update on the treatment of superficial mycoses.

  2012cites this paper
• Antifungal susceptibility of dermatophytes isolated from patients with chronic renal failure Perfil de suscetibilidade a antifúngicos de dermatófitos isolados de pacientes com insuficiência renal crônica

  2011cites this paper
• Antifungal susceptibility of dermatophytes isolated from patients with chronic renal failure.

  2011cites this paper
• Antifungal susceptibility patterns of yeasts and filamentous fungi isolated from nail infection

  2011cites this paper
• Antifungal susceptibility of dermatophytes isolated from patients with chronic renal failure

  2011cites this paper
• In Vitro Activities of New Triazole Antifungal Agents, Posaconazole and Voriconazole, Against Oral Candida Isolates from Patients Suffering from Denture Stomatitis

  2011cites this paper